IL5 and neoplasm: The nanoparticles formulated with mRNAs encoding IL-5 and IKK β reverse the immunosuppressive, tumor-supporting state of GAMs and reprogram them to M1 phenotype that induces anti-tumor immunity and promotes tumor regression